Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, et al. Prevalence of Parkinson’s disease across North America. NPJ Parkinson’s disease. 2018;4:21. https://doi.org/10.1038/s41531-018-0058-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet (London England). 2004;363 9423:1783–93. https://doi.org/10.1016/s0140-6736(04)16305-8.

Article  Google Scholar 

Pfeiffer RF. Non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2016;22(Suppl 1):119–22. https://doi.org/10.1016/j.parkreldis.2015.09.004.

Article  Google Scholar 

Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P. Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015;14 5:518–31. https://doi.org/10.1016/s1474-4422(15)00019-8.

Article  Google Scholar 

Walker L, Stefanis L, Attems J. Clinical and neuropathological differences between Parkinson’s disease, Parkinson’s disease dementia and dementia with Lewy bodies - current issues and future directions. J Neurochem. 2019;150 5:467–74. https://doi.org/10.1111/jnc.14698.

Article  CAS  Google Scholar 

Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, et al. Parkinson’s disease in China: a forty-year growing track of bedside work. Translational neurodegeneration. 2019;8:22. https://doi.org/10.1186/s40035-019-0162-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson Disease: a review. JAMA. 2020;323 6:548–60. https://doi.org/10.1001/jama.2019.22360.

Article  Google Scholar 

Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson’s disease. Lancet Neurol. 2021;20 7:559–72. https://doi.org/10.1016/s1474-4422(21)00061-2.

Article  CAS  Google Scholar 

Da-chao C. Clinical curative effect of Jiawei Jichuan Decoction in treatment of constipation of patients with Parkinson’s Disease. Syst Med. 2019;4 04:1–2. https://doi.org/10.19368/j.cnki.2096-1782.2019.04.001.

Article  Google Scholar 

Wei PENG, Yingjun OUYANG, Jianmin YU, Jingzhou CAI, Dan X. Clinical effect of jichuanjian decoction and acupoint application on the treatment of constipation in Parkinson’s disease. Guangzhou Med J. 2020;51 03:53–6.

Google Scholar 

Peng S, Wang C, Ma J, Jiang K, Jiang Y, Gu X, et al. Achyranthes bidentata polypeptide protects dopaminergic neurons from apoptosis in Parkinson’s disease models both in vitro and in vivo. Br J Pharmacol. 2018;175 4:631–43. https://doi.org/10.1111/bph.14110.

Article  CAS  Google Scholar 

Gao MR, Wang M, Jia YY, Tian DD, Liu A, Wang WJ, et al. Echinacoside protects dopaminergic neurons by inhibiting NLRP3/Caspase-1/IL-1β signaling pathway in MPTP-induced Parkinson’s disease model. Brain Res Bull. 2020;164:55–64. https://doi.org/10.1016/j.brainresbull.2020.08.015.

Article  CAS  PubMed  Google Scholar 

Yang X, Yv Q, Ye F, Chen S, He Z, Li W, et al. Echinacoside protects dopaminergic neurons through regulating IL-6/JAK2/STAT3 pathway in Parkinson’s Disease Model. Front Pharmacol. 2022;13:848813. https://doi.org/10.3389/fphar.2022.848813.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Y, Yang DD, Li XY, Fang DL, Zhou WJ. ZBP1 is a significant pyroptosis regulator for systemic lupus erythematosus. Annals of translational medicine. 2021;9 24:1773. https://doi.org/10.21037/atm-21-6193.

Article  CAS  Google Scholar 

Bian Z, Fan R, Xie L. A Novel cuproptosis-related prognostic gene signature and validation of Differential expression in Clear Cell Renal Cell Carcinoma. Genes. 2022;13:5. https://doi.org/10.3390/genes13050851.

Article  CAS  Google Scholar 

You J, Li H, Wei Y, Fan P, Zhao Y, Yi C, et al. Novel pyroptosis-related gene signatures identified as the prognostic biomarkers for bladder carcinoma. Front Oncol. 2022;12:881860. https://doi.org/10.3389/fonc.2022.881860.

Article  PubMed  PubMed Central  Google Scholar 

Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. https://doi.org/10.1186/1758-2946-6-13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan JH, Xu MM, Zhou LM, Gui ZW, Huang L, Li XG, et al. Integrating network pharmacology deciphers the action mechanism of Zuojin capsule in suppressing colorectal cancer. Phytomedicine: Int J phytotherapy phytopharmacology. 2022;96:153881. https://doi.org/10.1016/j.phymed.2021.153881.

Article  CAS  Google Scholar 

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47 D1:D607–d13. https://doi.org/10.1093/nar/gky1131.

Article  CAS  Google Scholar 

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13 11:2498–504. https://doi.org/10.1101/gr.1239303.

Article  CAS  Google Scholar 

Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc. 2007;2 10:2366–82. https://doi.org/10.1038/nprot.2007.324.

Article  CAS  Google Scholar 

Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinf (Oxford England). 2005;21 16:3448–9. https://doi.org/10.1093/bioinformatics/bti551.

Article  CAS  Google Scholar 

Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16 5:284–7. https://doi.org/10.1089/omi.2011.0118.

Article  CAS  Google Scholar 

Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–61. https://doi.org/10.1002/jcc.21334.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao P, Jiang F, Cheng J, Ma L, Zhang Y, Zhao Y. Traditional Chinese Medicine for Cardiovascular Disease: evidence and potential mechanisms. J Am Coll Cardiol. 2017;69 24:2952–66. https://doi.org/10.1016/j.jacc.2017.04.041.

Article  Google Scholar 

Huang K, Zhang P, Zhang Z, Youn JY, Wang C, Zhang H, et al. Traditional chinese medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843. https://doi.org/10.1016/j.pharmthera.2021.107843.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo H, Liu MP. Mechanism of traditional chinese medicine in the treatment of allergic rhinitis. Chin Med J. 2013;126 4:756–60.

Google Scholar 

Kong LY, Tan RX. Artemisinin, a miracle of traditional chinese medicine. Nat Prod Rep. 2015;32 12:1617–21. https://doi.org/10.1039/c5np00133a.

Article  CAS  Google Scholar 

Feng ST, Wang XL, Wang YT, Yuan YH, Li ZP, Chen NH, et al. Efficacy of traditional chinese medicine combined with selective serotonin reuptake inhibitors on the treatment for Parkinson’s Disease with Depression: a systematic review and Meta-analysis. Am J Chin Med. 2021;49 3:627–43. https://doi.org/10.1142/s0192415x21500282.

Article  CAS  Google Scholar 

Wang L, Yang YF, Chen L, He ZQ, Bi DY, Zhang L, et al. Compound Dihuang Granule inhibits Nigrostriatal Pathway apoptosis in Parkinson’s Disease by suppressing the JNK/AP-1 pathway. Front Pharmacol. 2021;12:621359. https://doi.org/10.3389/fphar.2021.621359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang ZY, Liu J, Zhu Z, Su CF, Sreenivasmurthy SG, Iyaswamy A, et al. Traditional chinese medicine compounds regulate autophagy for treating neurodegenerative disease: a mechanism review. Biomed pharmacotherapy = Biomedecine pharmacotherapie. 2021;133:110968. https://doi.org/10.1016/j.biopha.2020.110968.

Article  CAS  PubMed  Google Scholar 

Zhao Y, Qin L, Pan H, Liu Z, Jiang L, He Y, et al. The role of genetics in Parkinson’s disease: a large cohort study in chinese mainland population. Brain. 2020;143 7:2220–34. https://doi.org/10.1093/brain/awaa167.

Article  Google Scholar 

Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103 2:239 – 52; doi: 10.1016/s0092-8674(00)00116-1.

Newbern J, Zhong J, Wickramasinghe RS, Li X, Wu Y, Samuels I, et al. Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc Natl Acad Sci USA. 2008;105 44:17115–20. https://doi.org/10.1073/pnas.0805239105.

Article  Google Scholar 

Yao Z, Li J, Bian L, Li Q, Wang X, Yang X, et al. Nootkatone alleviates rotenone-induced Parkinson’s disease symptoms through activation of the PI3K/Akt signaling pathway. Phytother Res. 2022. https://doi.org/10.1002/ptr.7552.

Article  PubMed  Google Scholar 

Verma M, Callio J, Otero PA, Sekler I, Wills ZP, Chu CT. Mitochondrial calcium Dysregulation contributes to Dendrite Degeneration mediated by PD/LBD-Associated LRRK2 mutants. J neuroscience: official J Soc Neurosci. 2017;37 46:11151–65. https://doi.org/10.1523/jneurosci.3791-16.2017.

Article  CAS  Google Scholar 

Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010;2(1):a001008. https://doi.org/10.1101/cshperspect.a001008.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu T, Kim P, Luo Y. Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models. Neural regeneration research. 2017;12 9:1413–7. https://doi.org/10.4103/1673-5374.215243.

Article  CAS  Google Scholar 

Kamath T, Abdulraouf A, Burris SJ, Langlieb J, Gazestani V, Nadaf NM, et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson’s disease. Nat Neurosci. 2022;25 5:588–95. https://doi.org/10.1038/s41593-022-01061-1.

Article  CAS